KND Kindred Healthcare Inc.

SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Kindred Healthcare, Inc. and Encourages Investors to Contact the Firm for Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Kindred Healthcare, Inc. (NYSE: KND) (“Kindred Healthcare” or the “Company”) relating to the proposed buyout of Kindred Healthcare by a consortium of three companies: TPG Capital, Welsh, Carson, Anderson & Stowe and Humana Inc.

Under the terms of the agreement, Kindred Healthcare shareholders are anticipated to receive $9.00 in cash for each share of Kindred Healthcare common stock held. The firm’s investigation seeks to determine, among other things, whether the Company’s Board of Directors failed to satisfy their duties to shareholders, including whether the Board adequately pursued alternatives to the acquisition and whether the Board obtained the best price possible for the Company’s shares of common stock.

If you currently own common stock of Kindred Healthcare and believe that the proposed buyout price is too low, and you would like to learn more about the investigation being conducted, without cost or obligation to you, please contact Brower Piven either by email at [email protected] or by telephone at (410) 415-6616.

Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s.

EN
21/12/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Kindred Healthcare Inc.

9 directors sold

Nine Directors at Kindred Healthcare Inc sold 886,006 shares at 9.000USD. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

Kindred Healthcare, Inc. - March 2018 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

 PRESS RELEASE

Kindred Stockholders Approve Transaction with TPG Capital, Welsh, Cars...

LOUISVILLE, Ky.--(BUSINESS WIRE)-- Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that at its special meeting of stockholders, stockholders approved the transaction with affiliates of TPG Capital, Welsh, Carson, Anderson & Stowe and Humana Inc. (NYSE:HUM) (together, the “consortium”). The final vote results will be reported on a Form 8-K filed with the Securities and Exchange Commission. Benjamin A. Breier, President and Chief Executive Officer of Kindred, said, “We are pleased that the trans...

 PRESS RELEASE

Brigade Corrects Inaccuracies in Kindred Healthcare’s (KND) Press Re...

NEW YORK--(BUSINESS WIRE)-- Brigade Capital Management, LP (“Brigade”), on behalf of funds managed by it, today responded to yesterday’s press release by Kindred Healthcare, Inc. (NYSE: KND) (“Kindred” or the “Company”) to correct what Brigade views as misleading statements by Kindred. Brigade believes Kindred’s shareholders deserve better and should vote “NO” to the proposed acquisition of the Company by a consortium of Humana, TPG Capital and Welsh, Carson, Anderson & Stowe. Kindred’s March 27, 2018 press release states tha...

Kindred Healthcare, Inc.: Update to Credit Analysis

Kindred's credit profile is constrained by its high leverage and Medicare reimbursement risk. These risks are balanced by the company's good business diversity and large scale.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch